You just read:

CerSci Therapeutics Awarded Phase I STTR Grant From the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to Test Feasibility of a New Therapeutic Approach to Treat Migraine

News provided by

CerSci Therapeutics

Aug 21, 2018, 12:29 ET